137 related articles for article (PubMed ID: 22628428)
21. Fractalkine activates a signal transduction pathway similar to P2Y12 and is associated with impaired clopidogrel responsiveness.
Flierl U; Fraccarollo D; Lausenmeyer E; Rosenstock T; Schulz C; Massberg S; Bauersachs J; Schäfer A
Arterioscler Thromb Vasc Biol; 2012 Aug; 32(8):1832-40. PubMed ID: 22652599
[TBL] [Abstract][Full Text] [Related]
22. P2Y12 Receptor Modulates Sepsis-Induced Inflammation.
Liverani E; Rico MC; Tsygankov AY; Kilpatrick LE; Kunapuli SP
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):961-71. PubMed ID: 27055904
[TBL] [Abstract][Full Text] [Related]
23. Macrophage beta3 integrin suppresses hyperlipidemia-induced inflammation by modulating TNFalpha expression.
Schneider JG; Zhu Y; Coleman T; Semenkovich CF
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2699-706. PubMed ID: 17951320
[TBL] [Abstract][Full Text] [Related]
24. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice.
Babaev VR; Yancey PG; Ryzhov SV; Kon V; Breyer MD; Magnuson MA; Fazio S; Linton MF
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1647-53. PubMed ID: 15947238
[TBL] [Abstract][Full Text] [Related]
25. P2y12 Receptor Promotes Pressure Overload-Induced Cardiac Remodeling via Platelet-Driven Inflammation in Mice.
Wu L; Zhao F; Dai M; Li H; Chen C; Nie J; Wang P; Wang DW
Hypertension; 2017 Oct; 70(4):759-769. PubMed ID: 28827474
[TBL] [Abstract][Full Text] [Related]
26. Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression.
Morris-Rosenfeld S; Blessing E; Preusch MR; Albrecht C; Bierhaus A; Andrassy M; Nawroth PP; Rosenfeld ME; Katus HA; Bea F
Eur J Clin Invest; 2011 Nov; 41(11):1164-71. PubMed ID: 21418204
[TBL] [Abstract][Full Text] [Related]
27. Dextromethorphan reduces oxidative stress and inhibits atherosclerosis and neointima formation in mice.
Liu SL; Li YH; Shi GY; Tang SH; Jiang SJ; Huang CW; Liu PY; Hong JS; Wu HL
Cardiovasc Res; 2009 Apr; 82(1):161-9. PubMed ID: 19189960
[TBL] [Abstract][Full Text] [Related]
28. Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice.
Krohn R; Raffetseder U; Bot I; Zernecke A; Shagdarsuren E; Liehn EA; van Santbrink PJ; Nelson PJ; Biessen EA; Mertens PR; Weber C
Circulation; 2007 Oct; 116(16):1812-20. PubMed ID: 17893273
[TBL] [Abstract][Full Text] [Related]
29. Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein E-deficient mice.
Schober A; Bernhagen J; Thiele M; Zeiffer U; Knarren S; Roller M; Bucala R; Weber C
Circulation; 2004 Jan; 109(3):380-5. PubMed ID: 14691040
[TBL] [Abstract][Full Text] [Related]
30. Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development.
Guo J; de Waard V; Van Eck M; Hildebrand RB; van Wanrooij EJ; Kuiper J; Maeda N; Benson GM; Groot PH; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1014-9. PubMed ID: 15774908
[TBL] [Abstract][Full Text] [Related]
31. Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl/6 and apoE-/- mice.
Sachais BS; Turrentine T; Dawicki McKenna JM; Rux AH; Rader D; Kowalska MA
Thromb Haemost; 2007 Nov; 98(5):1108-13. PubMed ID: 18000617
[TBL] [Abstract][Full Text] [Related]
32. [Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].
Luo RN; Tao LJ; Zhou J; Wang R; Lu MM; Fu X
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):743-8. PubMed ID: 22169423
[TBL] [Abstract][Full Text] [Related]
33. Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo.
Hoyer FF; Steinmetz M; Zimmer S; Becker A; Lütjohann D; Buchalla R; Zimmer A; Nickenig G
J Mol Cell Cardiol; 2011 Dec; 51(6):1007-14. PubMed ID: 21884703
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice.
Brånén L; Hovgaard L; Nitulescu M; Bengtsson E; Nilsson J; Jovinge S
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2137-42. PubMed ID: 15345516
[TBL] [Abstract][Full Text] [Related]
35. Distinct roles for protein kinase C isoforms in regulating platelet purinergic receptor function.
Mundell SJ; Jones ML; Hardy AR; Barton JF; Beaucourt SM; Conley PB; Poole AW
Mol Pharmacol; 2006 Sep; 70(3):1132-42. PubMed ID: 16804093
[TBL] [Abstract][Full Text] [Related]
36. Decreased neurotrophin TrkB receptor expression reduces lesion size in the apolipoprotein E-null mutant mouse.
Kraemer R; Baker PJ; Kent KC; Ye Y; Han JJ; Tejada R; Silane M; Upmacis R; Deeb R; Chen Y; Levine DM; Hempstead B
Circulation; 2005 Dec; 112(23):3644-53. PubMed ID: 16330706
[TBL] [Abstract][Full Text] [Related]
37. Melagatran reduces advanced atherosclerotic lesion size and may promote plaque stability in apolipoprotein E-deficient mice.
Bea F; Kreuzer J; Preusch M; Schaab S; Isermann B; Rosenfeld ME; Katus H; Blessing E
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2787-92. PubMed ID: 16990551
[TBL] [Abstract][Full Text] [Related]
38. Egr-1 deficiency in bone marrow-derived cells reduces atherosclerotic lesion formation in a hyperlipidaemic mouse model.
Albrecht C; Preusch MR; Hofmann G; Morris-Rosenfeld S; Blessing E; Rosenfeld ME; Katus HA; Bea F
Cardiovasc Res; 2010 May; 86(2):321-9. PubMed ID: 20110335
[TBL] [Abstract][Full Text] [Related]
39. The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice.
Keul P; Tölle M; Lucke S; von Wnuck Lipinski K; Heusch G; Schuchardt M; van der Giet M; Levkau B
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):607-13. PubMed ID: 17158351
[TBL] [Abstract][Full Text] [Related]
40. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
